Navigation Links
Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
Date:1/30/2009

Stemedica Cell Technologies, Inc., a leader in adult stem cell production, announced today the appointment of Michael Bayer, MD, as Director, Medical Services. Dr. Bayer will be responsible for developing pre-clinical and clinical trial protocols for use by research centers conducting pre-clinical and clinical trials using Stemedica products.

San Diego, CA (PRWEB) January 30, 2009 -- Stemedica Cell Technologies, Inc., a leader in adult stem cell production, announced today the appointment of Michael Bayer, MD, as Director, Medical Services. Dr. Bayer will be responsible for developing pre-clinical and clinical trial protocols for use by research centers conducting pre-clinical and clinical trials using Stemedica products.

An Orthopedic Surgeon and Clinician, Dr. Bayer's specialty is Translational Medicine - taking laboratory research and results and applying them in new patient treatments.    World renowned for inventing an arthroscopic surgical technique for repairing rotator cuff injuries, Dr. Bayer has worked with major clinical research institutions and physicians around the world to bring new technology safely and successfully into the medical marketplace.

Dr. Bayer's new role at Stemedica was warmly welcomed by Dr. Nikolai Tankovich, President, Chief Medical Officer of Stemedica. "I am very impressed with Dr. Bayer's long track record of translating laboratory results to practical surgery and treatments. Dr. Bayer is a brilliant surgeon and clinician and we feel very fortunate to have attracted his interest and to have brought about this significant appointment. I am looking forward to working with him to advance our work," said Dr. Tankovich.

For the past year, Dr. Bayer has been involved in a Fellowship Study Prog
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related biology technology :

1. Nektar Announces Retirement of Irwin Lerner from Board of Directors
2. Cardica Announces Fiscal 2009 Second Quarter Financial Results
3. Repligen Announces Conference Call of Third Quarter Fiscal Year 2009 Results
4. Omnitura Therapeutics Announces Private Placement Financing
5. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
6. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
7. Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
8. Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
9. Bion Announces PENNVEST Board Approves $7.8 Million Financing for Kreider Farms Dairy Project
10. Medarex Announces Allowance of Investigational New Drug Application for Companys First Antibody-Drug Conjugate, MDX-1203
11. XTL Biopharmaceuticals Announces Receipt of NASDAQ Notice of Delisting

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
(Date:11/24/2009)... The New York investment bank KTA Cap... has agreed an AU$6.7 mil convertible note private... private placement was arranged by KTA Capital as ... New York (PRWEB) November...ank KTA Capital, LLC ("KTA Capital") has...
(Date:11/24/2009)...CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNewswire...oday it is acquiring the assets of Hyland Seeds, a...o. The addition of Hyland Seeds will further expan...company anticipates the introduction of SmartStax...olerant Trait Technology in corn in 2012. The tran...
(Date:11/24/2009)..., ST. LOUIS, Nov. 24 Si...resenting at the NASDAQ OMX conference on Tuesday,.../CST. Interested parties may listen via live audio.../inve s tor.sig m a a ldrich.com/ . Users ... ,, About Sigma-Aldrich: Sigma-Aldrich is ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /...sdaq: DCGN ) today announced the approval of all o...ourt for the District of Delaware,(the "Bankruptcy...ion for,relief under Chapter 11 of the United Stat..., The orders issued by the Bankruptcy Court a...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
....A., a,French drug and diagnostic discovery compan...lts for the year ending December 31, 2007., 2007 ...c research collaboration with,Allergan Inc., (NYSE...ls with,the first compound resulting from the coll...ncaise de Securite Sanitaire des,Produits de Sante...
...he German,Bundestag (Lower House) is due to vote o...posing poles in the debate on embryonic stem cell ...s are calling for the complete,liberalisation of s... of a,general ban on the use of human stem cells, ...ag debates on a new regulation, Blasticon,Biotechn...
...rapy to be Superior to Statins Alone, in Decreas...lobin 2-2 Genotype,...Inc. (Amex: SYI ) announces the publication of a ...nstrating that the addition of,vitamin E to statin...rt,attack, stroke and cardiovascular death) than s...
Other Biology Technology:ExonHit Therapeutics - 2007 Financial Results 2ExonHit Therapeutics - 2007 Financial Results 3ExonHit Therapeutics - 2007 Financial Results 4ExonHit Therapeutics - 2007 Financial Results 5ExonHit Therapeutics - 2007 Financial Results 6ExonHit Therapeutics - 2007 Financial Results 7ExonHit Therapeutics - 2007 Financial Results 8ExonHit Therapeutics - 2007 Financial Results 9ExonHit Therapeutics - 2007 Financial Results 10ExonHit Therapeutics - 2007 Financial Results 11ExonHit Therapeutics - 2007 Financial Results 12A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 2A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 3Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 2Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 3Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 4
(Date:11/25/2009)... , Athens, Ga. Bacteria don,t have easy lives. I...e the bugs, they have natural enemies called bacte...Earth every two days. , Still, bacteria and ano... discovered in extreme environments such as deep-s... part because they have a built-in defense system ...
(Date:11/25/2009)... , MADISON, WI, NOVEMBER 25, 2009 Soil is the li...here, and hydrosphere meet. Despite that, many stu...nts, but nothing more. Soil science educators are ...he public recognize the critical importance of soi... by soil science and earth science teachers at Uni...
(Date:11/25/2009)... , LA JOLLA, CAWhen you eat may be just as vita...s at the Salk Institute for Biological Studies. Th...xing and waning of thousands of genes in the liver...lled by food intake and not by the body,s circadia...eding time determines the activity of a large numb...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Feeding the clock 2Feeding the clock 3Mechanism for potential Friedreichs ataxia drug uncovered 10111 1Mechanism for potential Friedreichs ataxia drug uncovered 10111 2Mechanism for potential Friedreichs ataxia drug uncovered 10111 3Yale engineers track bacterias kayak paddle like motion for first time 10108 1Yale engineers track bacterias kayak paddle like motion for first time 10108 2Studies Find PSA Screening Unreliable 58348 1Studies Find PSA Screening Unreliable 58348 2Studies Find PSA Screening Unreliable 58348 3
...he University of Montana, University of California...Davis have shown that a top predator strongly affe... food web by eating organisms that transport nutri...alters Aleutian island plant communities by thwart...ary issue of Ecological Monographs. , As any biolo...
...born with HIV infection may be most effective when...ng to a study published in the April 1 issue of Th...line. , Uncertainty over when to start antiretrovi...heir mothers revolves around balancing the benefit...and costs of life-long therapy begun within months...
...f Marine Life, with the Huntsman Marine Science Ce...y the first count of known marine species in the G...revious estimates. , The count is 3,317 species ...t migrate to the region seasonally. The Canadian-...Marine Life. The count comes from the new Gulf of ...
Other Biology News:Not just the birds 2Not just the birds 3New study shows benefit of early therapy in HIV-infected infants 2The diversity of marine life in the Gulf of Maine region is much greater than previously thought 2The diversity of marine life in the Gulf of Maine region is much greater than previously thought 3The diversity of marine life in the Gulf of Maine region is much greater than previously thought 4The diversity of marine life in the Gulf of Maine region is much greater than previously thought 5
...rade; SAPK/JNK (Thr183/Tyr185) Antibody Kit Kit I...dy, Catalog #9251, 200 ul SAPK/JNK (56G8) Rabbit m...Catalog #9253, (4 Western mini-blots) Anti-rabbit ...ti-biotin IgG, HRP-linked Antibody, Catalog #7075,...
Duck Anti-Phenytoin-BSA Antibody, Unconjugated from Good Biotech Corp
Rabbit Anti-GPCR TM7XN1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-MEF2A, phospho (Thr312) Antibody, Unconjugated from Spring Bioscience
Biology Products: